Lataa...
Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
(211)At is an α-emitter that has similar chemical properties to iodine and is used in targeted α-therapy. In the present study, we added ascorbic acid (AA) to (211)At solution to increase the radiochemical purity of astatide and evaluated its efficacy against differentiated thyroid cancer, which is...
Tallennettuna:
| Julkaisussa: | J Nucl Med |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Society of Nuclear Medicine
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735285/ https://ncbi.nlm.nih.gov/pubmed/30796173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222638 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|